DK0941318T3 - Håndvægtformede konstruerede ekspressionssystemer til genterapi - Google Patents

Håndvægtformede konstruerede ekspressionssystemer til genterapi

Info

Publication number
DK0941318T3
DK0941318T3 DK97949949T DK97949949T DK0941318T3 DK 0941318 T3 DK0941318 T3 DK 0941318T3 DK 97949949 T DK97949949 T DK 97949949T DK 97949949 T DK97949949 T DK 97949949T DK 0941318 T3 DK0941318 T3 DK 0941318T3
Authority
DK
Denmark
Prior art keywords
expression
dumbbell
construct
shaped gene
gene expression
Prior art date
Application number
DK97949949T
Other languages
English (en)
Other versions
DK0941318T5 (da
Inventor
Burghardt Wittig
Claas Junghans
Original Assignee
Soft Gene Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soft Gene Gmbh filed Critical Soft Gene Gmbh
Application granted granted Critical
Publication of DK0941318T3 publication Critical patent/DK0941318T3/da
Publication of DK0941318T5 publication Critical patent/DK0941318T5/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition
    • Y10S977/916—Gene therapy
DK97949949T 1996-11-13 1997-11-13 Håndvægtformede konstruerede ekspressionssystemer til genterapi DK0941318T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19648625A DE19648625A1 (de) 1996-11-13 1996-11-13 Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer
PCT/DE1997/002704 WO1998021322A1 (de) 1996-11-13 1997-11-13 Design-prinzip für die konstruktion von expressionskonstrukten für die gentherapie

Publications (2)

Publication Number Publication Date
DK0941318T3 true DK0941318T3 (da) 2001-05-21
DK0941318T5 DK0941318T5 (da) 2002-02-18

Family

ID=7812619

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97949949T DK0941318T5 (da) 1996-11-13 1997-11-13 Håndvægtformede konstruerede ekspressionssystemer til genterapi

Country Status (9)

Country Link
US (2) US6451593B1 (da)
EP (1) EP0941318B9 (da)
AT (1) ATE198767T1 (da)
AU (1) AU5308698A (da)
DE (3) DE19648625A1 (da)
DK (1) DK0941318T5 (da)
ES (1) ES2155702T4 (da)
HK (1) HK1024714A1 (da)
WO (1) WO1998021322A1 (da)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19648625A1 (de) * 1996-11-13 1998-05-14 Soft Gene Gmbh Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer
DE19753182A1 (de) * 1997-11-21 1999-07-29 Claas Junghans Topologisch fixierte matrixgebundene Nukleinsäure
DE19826758C1 (de) * 1998-06-15 1999-10-21 Soft Gene Gmbh Darstellung von linearen kovalent geschlossenen DNA-Molekülen als Expressionskonstrukte
AU783294B2 (en) * 1999-03-24 2005-10-13 Board Of Regents, The University Of Texas System Linear and circular expression elements
DE19935756A1 (de) * 1999-07-27 2001-02-08 Mologen Forschungs Entwicklung Kovalent geschlossenes Nukleinsäuremolekül zur Immunstimulation
GB9924981D0 (en) * 1999-10-21 1999-12-22 Univ Manchester Gene therapy
DE10025920A1 (de) * 2000-05-27 2001-12-06 Mologen Forschungs Entwicklung Verfahren und Mittel zur Behandlung von Immunreaktionen am Auge
DE10119005A1 (de) * 2001-04-18 2002-10-24 Roche Diagnostics Gmbh Verfahren zur Proteinexpression ausgehend von stabilisierter linearer kurzer DNA in zellfreien in vitro-Transkription/Translations-Systemen mit Exonuklease-haltigen Lysaten oder in einem zellulären System enthaltend Exonukleasen
AU2002329176A1 (en) * 2001-05-25 2002-12-23 The Trustees Of The University Of Pennsylvania Targeted particles and methods of using the same
WO2003031469A2 (de) * 2001-10-02 2003-04-17 Mologen Ag Mittel zur verbesserung der immunantwort
EP1432805B1 (de) * 2001-10-02 2005-05-18 Mologen AG Dna-expressionskonstrukt zur behandlung von infektionen mit leishmaniose
US20150050317A1 (en) * 2013-08-19 2015-02-19 Mologen Ag Means for Eliciting an Immune Response and a Method Therefor
AU2002326961A1 (en) * 2001-10-10 2003-04-22 Centocor, Inc. Nucleic acid vaccines using tumor antigen encoding nucleic acids with cytokine adjuvant encoding nucleic acid
ITMN20020013A1 (it) 2002-04-04 2003-10-06 Amfag Spa Doccia estraibile da cucina
AU2003260243A1 (en) * 2002-07-19 2004-03-03 Mologen Ag Dna expression construct for multiple gene expression
ATE466085T1 (de) * 2002-09-09 2010-05-15 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
EP1553977B1 (de) * 2002-09-23 2006-08-09 Mologen AG Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze
WO2004096238A1 (en) * 2003-04-01 2004-11-11 Centocor, Inc. Nucleic acid compositions and methods for use
DK1631672T3 (da) * 2003-06-10 2007-01-02 Mologen Ag Cirkulært ekspressionskonstrukt til genterapeutiske anvendelser
US20050137156A1 (en) * 2003-08-09 2005-06-23 Johnston Stephen A. Methods and compositions for generating an immune response
WO2005039633A1 (de) 2003-10-24 2005-05-06 Mologen Ag Mittel zur behandlung von infektionen mit leishmanien
WO2005063280A1 (de) 2003-12-30 2005-07-14 Mologen Ag Allogenes tumortherapeutikum
US7613295B2 (en) * 2004-02-18 2009-11-03 Harris Corporation Cryptographic device and associated methods
WO2005080567A1 (de) 2004-02-20 2005-09-01 Mologen Ag Substituiertes, nicht-kodierendes nukleinsäuremolekül zur therapeutischen und prophylaktischen immunstimulation in menschen und höheren tieren
EP1749096B1 (de) * 2004-05-28 2013-07-17 Mologen AG Herstellungsverfahren geeigneter dna-konstrukte zur spezifischen hemmung der genexpression durch rna-interferenz
EP1786474B1 (en) * 2004-08-12 2011-06-01 Cedars-Sinai Medical Center Combined gene therapy for the treatment of macroscopic gliomas
KR20080082956A (ko) 2005-09-15 2008-09-12 노보솜 아게 양쪽성 리포솜의 개선 또는 양쪽성 리포솜에 관련된 개선
ES2421314T3 (es) * 2005-11-25 2013-08-30 Mologen Ag Constructos de ADN para la inhibición específica de la expresión génica mediante interferencia de ARN
EP2462924A3 (en) 2006-10-13 2013-01-23 Marina Biotech, Inc. Improvements in or relating to amphoteric liposomes.
US8883493B2 (en) * 2007-01-30 2014-11-11 Cedars-Sinai Medical Center Adenoviral vector comprising herpes simplex virus type 1 thymidine kinase and a transgene for increasing the expression of the transgene
DE102007029471A1 (de) 2007-06-20 2008-12-24 Novosom Ag Neue fakultativ kationische Sterole
GB0901593D0 (en) 2009-01-30 2009-03-11 Touchlight Genetics Ltd Production of closed linear DNA
KR101954912B1 (ko) 2009-07-09 2019-03-08 노보솜 베르발퉁스 게엠베하 이미노 지질을 포함하는 양쪽성 리포좀
GB201013153D0 (en) * 2010-08-04 2010-09-22 Touchlight Genetics Ltd Primer for production of closed linear DNA
GB2483462A (en) 2010-09-08 2012-03-14 Mologen Ag Use of a dumbbell-shaped DNA construct for the treatment of cancer through jet-injection administration
GB201021873D0 (en) 2010-12-23 2011-02-02 Mologen Ag DNA expression construct
WO2013034687A1 (en) 2011-09-09 2013-03-14 Universität Bern Verwaltungsdirektion Avibacterium paragallinarum rtx toxin
KR102168813B1 (ko) 2013-03-08 2020-10-22 옥스포드 나노포어 테크놀로지즈 리미티드 효소 정지 방법
GB201403096D0 (en) 2014-02-21 2014-04-09 Oxford Nanopore Tech Ltd Sample preparation method
GB201418159D0 (en) * 2014-10-14 2014-11-26 Oxford Nanopore Tech Ltd Method
EP4098753A1 (en) * 2014-10-23 2022-12-07 Ricardo Mancebo Reagents and methods for isothermal chain reaction
AU2015374385B2 (en) 2014-12-31 2020-08-06 Checkmate Pharmaceuticals, Inc. Combination tumor immunotherapy
GB201509578D0 (en) * 2015-06-03 2015-07-15 Univ Singapore Vectors
LU92821B1 (en) 2015-09-09 2017-03-20 Mologen Ag Combination comprising immunostimulatory oligonucleotides
GB2542425A (en) 2015-09-21 2017-03-22 Mologen Ag Means for the treatment of HIV
EP3436066A1 (en) 2016-04-01 2019-02-06 Checkmate Pharmaceuticals, Inc. Fc receptor-mediated drug delivery
GB201609220D0 (en) 2016-05-25 2016-07-06 Oxford Nanopore Tech Ltd Method
GB201807793D0 (en) 2018-05-14 2018-06-27 Oxford Nanopore Tech Ltd Method
US20210346306A1 (en) 2018-05-23 2021-11-11 Modernatx, Inc. Delivery of dna
EP3854419A1 (en) * 2020-01-24 2021-07-28 Univerzita Karlova, Lekarska fakulta v Plzni Dna conjugate and method of transformation of genes into cells
GB202014772D0 (en) 2020-09-18 2020-11-04 Lightbio Ltd Nucleic acid construct
WO2022240806A1 (en) 2021-05-11 2022-11-17 Modernatx, Inc. Non-viral delivery of dna for prolonged polypeptide expression in vivo
GB202204112D0 (en) 2022-03-23 2022-05-04 Lightbio Ltd Linear construct

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
EP1550713A3 (en) 1994-01-21 2007-09-12 Powderject Vaccines, Inc. Gas driven gene delivery instrument
DE4416784A1 (de) * 1994-05-09 1995-11-30 Soft Gene Gmbh Methode zur Anreicherung von Zellen, die durch ballistischen Transfer modifiziert wurden
FR2731014B1 (fr) 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa Molecules d'adn, preparation et utilisation en therapie genique
DE19510696A1 (de) 1995-03-14 1996-09-19 Soft Gene Gmbh Vorrichtung zur Druckverteilung im Kopfstück einer Apparatur zum ballistischen Transfer von Zellen
FR2732971B1 (fr) * 1995-04-13 1997-07-04 Genset Sa Oligonucleotide sens inhibiteur de virus herpes simplex (hsv) a structure en haltere
DE19648625A1 (de) * 1996-11-13 1998-05-14 Soft Gene Gmbh Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer

Also Published As

Publication number Publication date
DK0941318T5 (da) 2002-02-18
US6451593B1 (en) 2002-09-17
US7074772B2 (en) 2006-07-11
HK1024714A1 (en) 2000-10-20
WO1998021322A1 (de) 1998-05-22
ES2155702T4 (es) 2002-12-16
DE19648625A1 (de) 1998-05-14
EP0941318B9 (de) 2001-12-19
ES2155702T3 (es) 2001-05-16
EP0941318A1 (de) 1999-09-15
DE59702936D1 (de) 2001-02-22
EP0941318B1 (de) 2001-01-17
US20030054392A1 (en) 2003-03-20
AU5308698A (en) 1998-06-03
ATE198767T1 (de) 2001-02-15
DE19781276D2 (de) 1999-09-30

Similar Documents

Publication Publication Date Title
DK0941318T3 (da) Håndvægtformede konstruerede ekspressionssystemer til genterapi
FR19C1020I1 (fr) Nouvelles molecules b7-4 et leurs utilisations
AU7599500A (en) Novel gl50 molecules and uses therefor
AP1678A (en) Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems.
DE69534733D1 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
AU3217100A (en) Methods of use of a novel lysyl oxidase-related protein
MXPA04004561A (es) Distribuidor de aire para sistema de biolixiviacion.
WO2001073028A3 (en) A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor
AU2002211446A1 (en) 32144, a human fatty acid amide hydrolase and uses thereof
AU2002320301A1 (en) Novel pgc-1 isoforms and uses therefor
WO2000052164A3 (en) Potassium channel molecules and uses therefor
WO2001075121A3 (en) 16836, a human phospholipase c family member and uses thereof
WO2001092495A3 (en) A human lysyl ixodase (47765) and uses thereof
AU2001253258A1 (en) Human trp-like calcium channel protein-2 (tlcc-2)
WO2001075076A3 (en) 33167, a novel human hydrolase and uses therefor
DE60124910D1 (de) Menschliche twik-8 moleküle und ihre verwendung
MXPA03002557A (es) Interactores de canales del potasio y sus usos.
WO2002024898A3 (en) 47647, a human lipase and uses therefor
WO2000018211A8 (en) A novel cochlear gene coch5b2 and uses therefor
WO2002020739A3 (en) Human matrix metalloproteinase
WO2003020912A3 (en) Novel clark protein and nucleic acid molecules and uses therefor
AU2002234132A1 (en) 13245, a novel human myotonic dystrophy type protein kinase and uses therefor
WO2002006485A3 (en) 47885, a novel human ubiquitin-activating enzyme and uses therefor
AU2001285204A1 (en) Atcr-1, a human acyltransferase and uses thereof
WO2001079293A3 (en) Human cadherin molecules and uses therefor